This is a clinical research study for participants with high blood pressure.
This is a 3-part study. In Parts A and B, the main purpose is to evaluate the safety and tolerability of the study drug known as LY3561774 in participants with dyslipidemia (high blood fat levels). How the body processes the study drug and the effect of the study drug on blood fat levels will also be investigated. The study may last up 52, 56 and 28 weeks for each participant in Parts A and B, respectively. There are up to 22, 26 and 16 visits in Parts A and B, respectively.
To qualify participants must be:
- Age 18-65
- Have Dyslipidemia or high blood pressure
- Cannot have Type 2 Diabetes
- Cannot have been in a study in the last 30 days